(Q42726637)

5 November 2017

title

In vitro antifungal activity of DNA topoisomerase inhibitors (English)

1 reference

5 November 2017

1 reference

ChEBI release 2020-05-28

Dietmar Steverding

1

0 references

author name string

Penelope Evans

2

1 reference

5 November 2017

Leon Msika

3

1 reference

5 November 2017

Benjamin Riley

4

1 reference

5 November 2017

Jerome Wallington

5

1 reference

5 November 2017

Silke Schelenz

6

1 reference

5 November 2017

publication date

22 September 2011

1 reference

5 November 2017

1 reference

5 November 2017

volume

50

1 reference

5 November 2017

issue

3

1 reference

5 November 2017

page(s)

333-336

1 reference

Epidemiology of invasive fungal infection

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

Echinocandin antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

Characterization of DNA topoisomerase I from Candida albicans as a target for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

The topoisomerase I gene from Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

Cloning and characterization of the Aspergillus nidulans DNA topoisomerase I gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

Cloning and characterization of the gene encoding Aspergillus nidulans DNA topoisomerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

In vitro effect of DNA topoisomerase inhibitors on Candida albicans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

Usefulness of a colorimetric method for testing antifungal drug susceptibilities of Aspergillus species to voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

Antimicrobial activity of cytotoxic drugs may influence isolation of bacteria and fungi from blood cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

Idarubicin inhibits the growth of bacteria and yeasts in an automated blood culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13693786.2011.609186

10.3109/13693786.2011.609186

21 January 2018

Identifiers

DOI

1 reference

5 November 2017

1 reference